Bhavna Chopra

Bhavna Chopra

Auto-generated profile, based on publicly available information

Bhavna Chopra

Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2014 in Expert Opinion on Biological Therapy
Verified
Journal Article
Open access
BCBhavna Chopra
Bhavna Chopra
KSKalathil K Sureshkumar
Kalathil K Sureshkumar
Calcineurin inhibitors (CNIs) are the cornerstone of immunosuppression after transplantation but can exert negative effects on chronic allograft function and metabolic profile. Belatacept, a selective co-stimulation blocker of T cells, is the first biologic agent approved for maintenance immunosuppression in kidney transplantation. Studies reveal better preservation of glomerular filtration rate and improved metabolic end points with belatacept when compared to CNIs. Increased incidence of acute rejection is noted with belatacept but overall graft survival looked similar at 5 years. Risk for posttransplant lymphoproliferative disorder is higher in Epstein-Barr virus-seronegative recipients of belatacept. Belatacept seems to be a promising drug, and further experience with its use will define its future role.

1 October 2020 in Transplant International
Verified
Journal Article
Closed access
PDF file
KSKalathil K. Sureshkumar
Kalathil K. Sureshkumar
SLShelly Lyons
Shelly Lyons
BCBhavna Chopra
Bhavna Chopra
Click on the article title to read more.


27 January 2025 in Clinical Transplantation
Verified
Journal Article
Closed access
SCStalin Canizares
Stalin Canizares
AMAdriana Montalvan
Adriana Montalvan
DEDevin Eckhoff
Devin Eckhoff
KSKalathil K. Sureshkumar
Kalathil K. Sureshkumar
BCBhavna Chopra
Bhavna Chopra

5 December 2024 in Clinical Transplantation
Verified
Journal Article
Closed access
GCGabriel Cojuc-Konigsberg
Gabriel Cojuc-Konigsberg
BRBelen Rivera
Belen Rivera
SCStalin Cañizares
Stalin Cañizares
MPMartha Pavlakis
Martha Pavlakis
DEDevin Eckhoff
Devin Eckhoff
BCBhavna Chopra
Bhavna Chopra

16 September 2024 in Kidney360
Verified
Journal Article
Open access
RCRitah R Rae Chumdermpadetsuk
Ritah R Rae Chumdermpadetsuk
AMAdriana Montalvan
Adriana Montalvan
SCStalin Canizares
Stalin Canizares
BCBhavna Chopra
Bhavna Chopra
MPMartha Pavlakis
Martha Pavlakis
DEDevin Eckhoff
Devin Eckhoff
Key Points: Female overrepresentation in living kidney donation stems from higher self-referral rates, not differences in approval or follow-through. Male volunteers are not more likely to be declined as donors due to medical contraindications, contrary to common assumptions. Engaging more male volunteers in living donation could expand access to kidney transplantation and reduce waitlist times. Background: Multiple studies have shown that female volunteers are living donors (LDs) for kidney transplantation at higher rates than male volunteers. However, the underlying reasons for this observation are not well understood. We examined the LD evaluation process to determine the point at which sex imbalance arises. On the basis of a previous study, we hypothesized that both sexes are equally likely to become approved as LDs, but female volunteers are more likely to follow through with donation. Methods: This is a single-institution retrospective chart review of self-referrals for LD evaluation between January 2009 and December 2022. Self-referrals were identified using the Organ Transplant Tracking Record database and cross-referenced with billing data. Exclusion at each stage of evaluation was recorded and compared between sexes using log binomial regression; unadjusted and adjusted (for donor age, race, ethnicity, relationship to recipient, and recipient sex) risk ratios with 95% confidence interval were determined. Results: One thousand eight hundred sixty-one self-referrals were reviewed, including 1214 female (65.2%) and 647 male (34.8%) volunteers, resulting in 146 approvals and 125 donations (76/125, 60.8% female, 49/125, 39.2% male). Adjusted risk ratios indicated no significant differences between sexes in completing medical and/or psychosocial workup, having medical and/or psychosocial contraindications, being approved for donation, and proceeding with donation. The top medical contraindications for both sexes were obesity, hypertension, and nephrolithiasis. Conclusions: Female overrepresentation among LDs is likely due to the 1.9 times higher rate of self-referral for evaluation. After this point, both sexes were equally likely to complete workup, be approved, and follow through with donation. Increased efforts to engage male volunteers at the initial self-referral stage has the potential to expand access to LD kidney transplantation. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2024_12_26_KID0000000581.mp3